Carregant...
A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes
ABSTRACT: Oral semaglutide (Rybelsus(®)) is a glucagon-like peptide-1 (GLP-1) receptor agonist (GLP-1RA) with 94% homology to human GLP-1. It is the first GLP-1RA developed for oral administration, and it comprises a co-formulation of the peptide semaglutide with the absorption enhancer sodium N-(8-...
Guardat en:
| Publicat a: | Drugs |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8217049/ https://ncbi.nlm.nih.gov/pubmed/33964002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-021-01499-w |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|